Sabine Gaugris

1.2k total citations
20 papers, 903 citations indexed

About

Sabine Gaugris is a scholar working on Economics and Econometrics, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sabine Gaugris has authored 20 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Pharmacology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sabine Gaugris's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Asthma and respiratory diseases (4 papers). Sabine Gaugris is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Asthma and respiratory diseases (4 papers). Sabine Gaugris collaborates with scholars based in United States, United Kingdom and France. Sabine Gaugris's co-authors include Saugata Sen, Tracey Young, John Brazier, Donna Rowen, Galina Velikova, Robert P. Heaney, Steven Boonen, Henriette Kurth, Mike Thomas and D. Yin and has published in prestigious journals such as Blood, The American Journal of Gastroenterology and Clinical & Experimental Allergy.

In The Last Decade

Sabine Gaugris

18 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabine Gaugris United States 13 288 210 190 188 162 20 903
Shiva Sajjan United States 17 263 0.9× 43 0.2× 222 1.2× 109 0.6× 61 0.4× 37 829
Vasily Belozeroff United States 17 310 1.1× 114 0.5× 284 1.5× 35 0.2× 138 0.9× 39 1.0k
Lee Stern United States 15 121 0.4× 34 0.2× 170 0.9× 66 0.4× 71 0.4× 64 884
Juhi Kumar United States 13 243 0.8× 734 3.5× 97 0.5× 77 0.4× 4 0.0× 18 1.1k
Larry Radican United States 24 273 0.9× 23 0.1× 62 0.3× 15 0.1× 195 1.2× 59 1.9k
Allison Freeman United States 8 80 0.3× 67 0.3× 94 0.5× 13 0.1× 81 0.5× 9 905
Marit D. Solbu Norway 28 120 0.4× 158 0.8× 209 1.1× 4 0.0× 69 0.4× 67 2.1k
Katsuhiko Yano United States 9 193 0.7× 62 0.3× 66 0.3× 5 0.0× 54 0.3× 9 874
Alan Bell Canada 14 93 0.3× 16 0.1× 135 0.7× 14 0.1× 46 0.3× 53 997

Countries citing papers authored by Sabine Gaugris

Since Specialization
Citations

This map shows the geographic impact of Sabine Gaugris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Gaugris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Gaugris more than expected).

Fields of papers citing papers by Sabine Gaugris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Gaugris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Gaugris. The network helps show where Sabine Gaugris may publish in the future.

Co-authorship network of co-authors of Sabine Gaugris

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Gaugris. A scholar is included among the top collaborators of Sabine Gaugris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Gaugris. Sabine Gaugris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Jyotsna, et al.. (2020). PCN135 UTILITY VALUES IN PATIENTS WITH RR MULTIPLE MYELOMA - A SYSTEMATIC LITERATURE REVIEW. Value in Health. 23. S47–S47.
2.
3.
4.
Rowen, Donna, Tracey Young, John Brazier, & Sabine Gaugris. (2012). Comparison of Generic, Condition-Specific, and Mapped Health State Utility Values for Multiple Myeloma Cancer. Value in Health. 15(8). 1059–1068. 42 indexed citations
5.
Acaster, Sarah, Sabine Gaugris, Galina Velikova, Kwee Yong, & Adam Lloyd. (2012). Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey. Supportive Care in Cancer. 21(2). 599–607. 43 indexed citations
6.
Rowen, Donna, John Brazier, Tracey Young, et al.. (2011). Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30. Value in Health. 14(5). 721–731. 132 indexed citations
7.
Rowen, Donna, Tracey Young, John Brazier, & Sabine Gaugris. (2011). Comparison of generic, condition-specific and mapped health state utility values. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 2 indexed citations
8.
Jansen, Jeroen P., et al.. (2010). Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis. PharmacoEconomics. 28(4). 323–344. 11 indexed citations
9.
Linden, Michiel W. van der, Sabine Gaugris, Ernst J. Kuipers, et al.. (2009). COX‐2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors. Pharmacoepidemiology and Drug Safety. 18(10). 880–890. 10 indexed citations
10.
Rahme, Elham, Alan Barkun, Hacene Nedjar, Sabine Gaugris, & Douglas J. Watson. (2008). Hospitalizations for Upper and Lower GI Events Associated With Traditional NSAIDs and Acetaminophen Among the Elderly in Quebec, Canada. The American Journal of Gastroenterology. 103(4). 872–882. 92 indexed citations
11.
12.
Jansen, Jeroen P., Sabine Gaugris, Gert Bergman, & Shuvayu S. Sen. (2008). Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands. Current Medical Research and Opinion. 24(3). 671–684. 16 indexed citations
13.
Linden, Michiel W. van der, Sabine Gaugris, Ernst J. Kuipers, et al.. (2008). Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands. Current Medical Research and Opinion. 25(1). 195–204. 13 indexed citations
14.
Jackson, Christian, Sabine Gaugris, Saugata Sen, & D. J. Hosking. (2007). The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM. 100(4). 185–192. 101 indexed citations
15.
Gaugris, Sabine, et al.. (2006). Burden of Concomitant Allergic Rhinitis in Adults with Asthma. Journal of Asthma. 43(1). 1–7. 77 indexed citations
16.
Bousquet, Jean, Sabine Gaugris, Vasilisa Sazonov Kocevar, et al.. (2006). Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clinical & Experimental Allergy. 36(2). 249–249. 12 indexed citations
17.
Bousquet, Jean, Sabine Gaugris, Vasilisa Sazonov Kocevar, et al.. (2005). Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clinical & Experimental Allergy. 35(6). 723–727. 160 indexed citations
18.
Gaugris, Sabine, et al.. (2005). Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 98(9). 667–676. 154 indexed citations
19.
Durand‐Zaleski, Isabelle, et al.. (2003). An economic evaluation of Losartan therapy in type 2 diabetic patients with nephropathy: an analysis of the RENAAL study adapted to France. Diabetes & Metabolism. 29(1). 29–35. 15 indexed citations
20.
Fagnani, Francis, et al.. (2003). Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France — 2001). Diabetes & Metabolism. 29(1). 58–64. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiva Sajjan Breakdown of academic impact, for papers by Vasily Belozeroff Breakdown of academic impact, for papers by Lee Stern Breakdown of academic impact, for papers by Juhi Kumar Breakdown of academic impact, for papers by Larry Radican Breakdown of academic impact, for papers by Allison Freeman Breakdown of academic impact, for papers by Marit D. Solbu Breakdown of academic impact, for papers by Katsuhiko Yano Breakdown of academic impact, for papers by Alan Bell
Rankless by CCL
2026